Sfoglia per Autore
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1
2016-01-01 Claudia Voena; Varesio, Lydia M.; Zhang, Liye; Menotti, Matteo; Poggio, Teresa; Panizza, Elena; Wang, Qi; Minero, Valerio G.; Fagoonee, Sharmila; Compagno, Mara; Altruda, Fiorella; Monti, Stefano; Chiarle, Roberto
A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment
2015-01-01 Alberti, Diego; Protti, Nicoletta; Toppino, Antonio; Deagostino, Annamaria; Lanzardo, Stefania; Bortolussi, Silva; Altieri, Saverio; Voena, Claudia; Chiarle, Roberto; Geninatti Crich, Simonetta; Aime, Silvio
The anaplastic lymphoma kinase as an oncogene in solid tumors
2015-01-01 Voena, Claudia; Peola, Silvia; Chiarle, Roberto
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors
2015-01-01 Voena, Claudia; Menotti, Matteo; Mastini, Cristina; Di Giacomo, Filomena; Longo, Dario Livio; Castella, Barbara; Merlo, Maria Elena Boggio; Ambrogio, Chiara; Wang, Qi; Minero, Valerio Giacomo; Poggio, Teresa; Martinengo, Cinzia; D'Amico, Lucia; Panizza, Elena; Mologni, Luca; Cavallo, Federica; Altruda, Fiorella; Butaney, Mohit; Capelletti, Marzia; Inghirami, Giorgio; Jänne, Pasi A; Chiarle, Roberto
Simple and Rapid InVivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology
2014-01-01 Blasco, Rafael B; Karaca, Elif; Ambrogio, Chiara; Cheong, Taek-Chin; Karayol, Emre; Minero, Valerio G.; Voena, Claudia; Chiarle, Roberto
Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts
2014-01-01 Ambrogio, Chiara*; Carmona, Francisco J.; Vidal, August; Falcone, Mattia; Nieto, Patricia; Romero, Octavio A.; Puertas, Sara; Vizoso, Miguel; Nadal, Ernest; Poggio, Teresa; Sánchez-Céspedes, Montserrat; Esteller, Manel; Mulero, Francisca; Voena, Claudia; Chiarle, Roberto; Barbacid, Mariano; Santamaría, David; Villanueva, Alberto
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis
2014-01-01 Martinengo, Cinzia; Poggio, Teresa; Menotti, Matteo; Scalzo, Maria Stella; Mastini, Cristina; Ambrogio, Chiara; Pellegrino, Elisa; Riera, Ludovica; Piva, Roberto; Ribatti, Domenico; Pastorino, Fabio; Perri, Patrizia; Ponzoni, Mirco; Wang, Qi; Voena, Claudia; Chiarle, Roberto
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1.
2013-01-01 Voena C;Di Giacomo F;Panizza E;D'Amico L;Boccalatte FE;Pellegrino E;Todaro M;Recupero D;Tabbò F;Ambrogio C;Martinengo C;Bonello L;Pulito R;Hamm J;Chiarle R;Cheng M;Ruggeri B;Medico E;Inghirami G
The battle against ALK resistance: successes and setbacks.
2012-01-01 Voena C; Chiarle R.
Anaplastic lymphoma kinase in human cancer
2011-01-01 Barreca A; Lasorsa E; Riera L; Machiorlatti R; Piva R; Ponzoni M; Kwee I; Bertoni F; Piccaluga PP; Pileri SA; Inghirami G; European T-Cell Lymphoma Study Group; Barreca A; Chiarle R; Cuccuru G; Inghirami G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Voena C; Fornari A; Novero D; Chilosi M; Zamò A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Piccaluga PP; Pileri S; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Konrad Muller-Hermelink H; Rosenwald A; Piris MA; Rodriguez ME
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity
2011-01-01 M. Polimeni; C. Voena; J. Kopecka; C. Riganti; G. Pescarmona; A. Bosia; D. Ghigo
Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.
2011-01-01 Riganti C; Voena C; Kopecka J; Corsetto PA; Montorfano G; Enrico E; Costamagna C; Rizzo AM; Ghigo D; Bosia A
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity
2011-01-01 Polimeni M; Voena C; Kopecka J; Riganti C; Pescarmona G; Bosia A; Ghigo D
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity
2011-01-01 Manuela Polimeni; Claudia Voena; Johanna Kopecka; Chiara Riganti; Gianpiero Pescarmona; Amalia Bosia; Dario Ghigo
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells
2010-01-01 I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.
2010-01-01 Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R.
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells
2009-01-01 Ambrogio C; Martinengo C; Voena C; Tondat F; Riera L; di Celle PF; Inghirami G; Chiarle R.
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL
2009-01-01 Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation
2008-01-01 Ambrogio C; Voena C; Manazza AD; Martinengo C; Costa C; Kirchhausen T; Hirsch E; Inghirami G; Chiarle R.
RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells
2008-01-01 Doublier S; Riganti C; Voena C; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1 | 2016 | Claudia Voena; Varesio, Lydia M.; Zhang, Liye; Menotti, Matteo; Poggio, Teresa; Panizza, Elena; Wang, Qi; Minero, Valerio G.; Fagoonee, Sharmila; Compagno, Mara; Altruda, Fiorella; Monti, Stefano; Chiarle, Roberto | |
| A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment | 2015 | Alberti, Diego; Protti, Nicoletta; Toppino, Antonio; Deagostino, Annamaria; Lanzardo, Stefania; Bortolussi, Silva; Altieri, Saverio; Voena, Claudia; Chiarle, Roberto; Geninatti Crich, Simonetta; Aime, Silvio | |
| The anaplastic lymphoma kinase as an oncogene in solid tumors | 2015 | Voena, Claudia; Peola, Silvia; Chiarle, Roberto | |
| Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors | 2015 | Voena, Claudia; Menotti, Matteo; Mastini, Cristina; Di Giacomo, Filomena; Longo, Dario Livio; Castella, Barbara; Merlo, Maria Elena Boggio; Ambrogio, Chiara; Wang, Qi; Minero, Valerio Giacomo; Poggio, Teresa; Martinengo, Cinzia; D'Amico, Lucia; Panizza, Elena; Mologni, Luca; Cavallo, Federica; Altruda, Fiorella; Butaney, Mohit; Capelletti, Marzia; Inghirami, Giorgio; Jänne, Pasi A; Chiarle, Roberto | |
| Simple and Rapid InVivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology | 2014 | Blasco, Rafael B; Karaca, Elif; Ambrogio, Chiara; Cheong, Taek-Chin; Karayol, Emre; Minero, Valerio G.; Voena, Claudia; Chiarle, Roberto | |
| Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts | 2014 | Ambrogio, Chiara*; Carmona, Francisco J.; Vidal, August; Falcone, Mattia; Nieto, Patricia; Romero, Octavio A.; Puertas, Sara; Vizoso, Miguel; Nadal, Ernest; Poggio, Teresa; Sánchez-Céspedes, Montserrat; Esteller, Manel; Mulero, Francisca; Voena, Claudia; Chiarle, Roberto; Barbacid, Mariano; Santamaría, David; Villanueva, Alberto | |
| ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis | 2014 | Martinengo, Cinzia; Poggio, Teresa; Menotti, Matteo; Scalzo, Maria Stella; Mastini, Cristina; Ambrogio, Chiara; Pellegrino, Elisa; Riera, Ludovica; Piva, Roberto; Ribatti, Domenico; Pastorino, Fabio; Perri, Patrizia; Ponzoni, Mirco; Wang, Qi; Voena, Claudia; Chiarle, Roberto | |
| The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. | 2013 | Voena C;Di Giacomo F;Panizza E;D'Amico L;Boccalatte FE;Pellegrino E;Todaro M;Recupero D;Tabbò F;Ambrogio C;Martinengo C;Bonello L;Pulito R;Hamm J;Chiarle R;Cheng M;Ruggeri B;Medico E;Inghirami G | |
| The battle against ALK resistance: successes and setbacks. | 2012 | Voena C; Chiarle R. | |
| Anaplastic lymphoma kinase in human cancer | 2011 | Barreca A; Lasorsa E; Riera L; Machiorlatti R; Piva R; Ponzoni M; Kwee I; Bertoni F; Piccaluga PP; Pileri SA; Inghirami G; European T-Cell Lymphoma Study Group; Barreca A; Chiarle R; Cuccuru G; Inghirami G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Voena C; Fornari A; Novero D; Chilosi M; Zamò A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Piccaluga PP; Pileri S; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Konrad Muller-Hermelink H; Rosenwald A; Piris MA; Rodriguez ME | |
| Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity | 2011 | M. Polimeni; C. Voena; J. Kopecka; C. Riganti; G. Pescarmona; A. Bosia; D. Ghigo | |
| Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. | 2011 | Riganti C; Voena C; Kopecka J; Corsetto PA; Montorfano G; Enrico E; Costamagna C; Rizzo AM; Ghigo D; Bosia A | |
| Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity | 2011 | Polimeni M; Voena C; Kopecka J; Riganti C; Pescarmona G; Bosia A; Ghigo D | |
| Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity | 2011 | Manuela Polimeni; Claudia Voena; Johanna Kopecka; Chiara Riganti; Gianpiero Pescarmona; Amalia Bosia; Dario Ghigo | |
| Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells | 2010 | I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia | |
| Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. | 2010 | Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R. | |
| NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells | 2009 | Ambrogio C; Martinengo C; Voena C; Tondat F; Riera L; di Celle PF; Inghirami G; Chiarle R. | |
| The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL | 2009 | Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G | |
| The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation | 2008 | Ambrogio C; Voena C; Manazza AD; Martinengo C; Costa C; Kirchhausen T; Hirsch E; Inghirami G; Chiarle R. | |
| RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells | 2008 | Doublier S; Riganti C; Voena C; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile